Dmcc Speciality Chemicals Limited · NSE:DMCC
Dmcc Speciality Chemicals — The Dharamsi Morarji Chemical Company — Q2 FY2021 Earnings Presentation
14 slides from Dmcc Speciality Chemicals's earnings presentation, November 2020
Slide 1: Cover letter to BSE on Q2 FY21 investor presentation
Listing/Compliance Department, 11.11.2020 BSE LTD, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, 400 001 BSE SCRIP CODE: 506405 Ref: Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. Subject: Investor Presentation on financial performance of Q2 Financial
Slide 2: Q2FY21 Earnings Presentation (November 2020)
Q2FY21 EARNINGS PRESENTATION (November 2020)
Slide 3: Safe Harbour
Safe This investor presentation has been prepared by Dharamsi Morarji Chemicals Company Limited (“DMCC”) and does not constitute a prospectus or placement memorandum or an offer to acquire any Harbour securities. This presentation or any other documentation or information (or any part thereof) deliv
Slide 4: Quarterly Updates
Q UA RT E RLY U P DAT ES MA N AG E ME N T CO MME N TA RY To view our corporate film Visit: https://bit.ly/3ePHS7S or Scan the QR code. U P DAT ES O N CA P E X FIN A N CIA L STAT E ME N T SU MMA RY CO NTAC T U S EA RNING S CA LL DE TA ILS
Slide 5: Financial Statement Summary
11.41% Financial Statement Summary Q2FY21 Revenue from Operations at INR 49.77 crores as compared to INR 44.68 Figures in INR Crores crores in Q2FY20 PARTICULARS Q2 FY21 Q1 FY21 Q2 FY20 Revenue from Operations 49.77 39.16 44.68 101.39% Total Income 55.88 39.53 44.89 Q2FY21 EBITDA at INR 15.43 crores
Slide 6: Financial Statement Summary
Financial Statement Summary Figures in INR Crores PARTICULARS H1FY21 FY20 H1FY20 Shareholders Fund 160.39 144.88 126.71 Non Current Liabilities 17.65 20.22 16.38 Current Liabilities 44.01 46.78 52.81 Total 222.05 211.88 187.87 Non Current Assets 122.83 112.48 101.73 Current Assets 99.21 99.40 86.13
Slide 7: Financial Statement Summary
Financial Statement Summary Figures in INR Crores PARTICULARS H1FY21 FY20 H1FY20 Cash Flow From Operating Activities 14.57 26.99 13.14 Cash Flow from Investing Activities (13.43) (16.84) (6.90) Cash Flow from Financing Activities (5.44) (5.65) (6.06) Net increase/ decrease in cash and cash (4.30) 4.
Slide 8: Management Remarks
Management Remarks FINANCIAL PERFORMANCE: PARTICULARS Q2FY21 Q1FY21 FUTURE OUTLOOK: The revenues of the company in • The company is witnessing a recovery in volumes in Sales of Specialty ~67% ~73% Q2FY21 increased by 11.41% to both bulk as well as specialty chemicals in the domestic chemicals 49.77
Slide 9: Update on Capex
Update on Capex Bulk chemicals at Specialty chemicals at Debottlenecking at Multipurpose plants Intermediates Dahej Dahej Roha at Dahej The company will be The company will invest 20. The company will invest ~ 10 The company will further The company has plans to investing 50 cr. in adding cr. in a d
Slide 10: Financial Statement Summary
Financial Statement Summary Figures in INR Crores PARTICULARS FY17 FY18 FY19 FY20 Revenue from operations 189.50 180.76 227.57 187.66 Total income 190.03 181.65 228.57 193.89 Total operating expense 160.34 158.75 175.07 166.08 EBITDA 30.21 23.78 54.5 34.04 EBITDA margins % 15.94% 13.16% 23.95% 18.14
Slide 11: Financial Statement Summary
Financial Statement Summary Figures in INR Crores PARTICULARS FY17 FY18 FY19 FY20 Shareholders Fund 59.83 72.77 115.78 144.88 Non Current Liabilities 18.40 23.85 19.53 20.22 Current Liabilities 70.80 57.79 52.96 46.77 Total 149.04 154.42 188.27 211.88 Non Current Assets 89.08 92.17 101.63 112.47 Cur
Slide 12: Financial Statement Summary
Financial Statement Summary Figures in INR Crores PARTICULARS FY17 FY18 FY19 FY20 Cash Flow From Operating Activities 28.99 18.36 20.85 26.99 Cash Flow from Investing Activities (8.31) (9.17) (12.69) (16.84) Cash Flow from Financing Activites (18.71) (9.05) (8.13) (5.65) Net increase/ decrease in ca
Slide 13: Get in Touch
Get in Touch MR. DILIP T GOKHALE MR. ABHISHEK MEHRA Sr. Executive Vice President & Investor Relations Advsior Company Secretary The Investment Lab The Dharamsi Morarji Chemical Co. Limited abhishek@theinvestmentlab.in dgokhle@dmcc.com
Slide 14: Q2FY21 Result Discussion
Q2FY21 RESULT DISCUSSION We cordially invite you to a conference call with the management of The Dharamsi Morarji Chemical Company Limited to discuss the Q2FY21 Result of the company. Management Participants Mr. Bimal Goculdas (Managing Director and CEO) Mr. Dilip Gokhale (Sr. Executive Vice Preside
The Dharamsi Morarji Chemical Company — Q2 FY2021 Earnings Presentation on 6ix